Harvest Fund Management Co., LTD Protagonist Therapeutics, Inc Transaction History
Harvest Fund Management Co., LTD
- $1.66 Billion
- Q3 2024
A detailed history of Harvest Fund Management Co., LTD transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 1,544 shares of PTGX stock, worth $60,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,544Holding current value
$60,246% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
247Shares Held
56.4MCall Options Held
76.3KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$229 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$225 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$212 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$124 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.92B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...